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Cultured RPE cellAccumulation of 7-ketocholesterol (7KCh) in tissues has been previously associated with various chronic aging
diseases. Orally ingested 7KCh is readily metabolized by the liver and does not pose a toxicity threat. However,
7KCh formed in situ, usually associated with lipoprotein deposits, can adversely affect surrounding tissues by
causing inﬂammation and cytotoxicity. In this study we have investigated various mechanisms for extra-
hepatic metabolism of 7KCh (e.g. hydroxylation, sulfation) and found only esteriﬁcation to fatty acids. The ester-
iﬁcation of 7KCh to fatty acids involves the combined action of cytosolic phospholipase A2 alpha (cPLA2α) and
sterol O-acyltransferase (SOAT1). Inhibition of either one of these enzymes ablates 7KCh-fatty acid ester
(7KFAE) formation. The 7KFAEs are not toxic and do not induce inﬂammatory responses. However,
they can be unstable and re-release 7KCh. The higher the degree of unsaturation, the more unstable the 7KFAE
(e.g. 18:0 N 18:1 N 18:2 N 18:3≫ 20:4). Biochemical inhibition and siRNA knockdown of SOAT1 and cPLA2α ab-
lated the 7KFAE synthesis in cultured ARPE19 cells, but had little effect on the 7KCh-induced inﬂammatory re-
sponse. Overexpression of SOAT1 reduced the 7KCh-induced inﬂammatory response and provided some
protection from cell death. This effect is likely due to the increased conversion of 7KCh to 7KFAEs, which reduced
the intracellular 7KCh levels. Addition of HDL selectively increased the efﬂux of 7KFAEs and enhanced the effect
of SOAT1 overexpression. Our data suggests an additional function for HDL in aiding extra-hepatic tissues to elim-
inate 7KCh by returning 7KFAEs to the liver for bile acid formation.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
7-Ketocholesterol (7KCh) is a well-studied oxysterol known for its
inﬂammatory and cytotoxic properties [1]. This oxysterol has been
implicated in the pathogenesis of most human age-related chronic dis-
eases [1,2]. It forms by the autooxidation of cholesterol and cholesterol-
fatty acid esters (CEs) which are abundantly found in lipoprotein
deposits [3]. In the retina, 7KCh has been found associatedwith lipopro-
tein deposit in Bruch's membrane and the choriocapillaris [4]. In mon-
key ocular tissues it was recently reported to accumulate as a process
of aging [5]. The levels are particularly pronounced in the retinal
pigment epithelium and choriocapillaris (RPE/CH) [5]. In some elderly
human RPE/CH tissues and drusen deposits the levels can be compara-
ble to those found in atheromatous plaques [5].
7-KCh is a potent inhibitor of 3-hydroxy-3-methylglutaryl coen-
zyme A reductase (HMG-CoA reductase), the rate limiting enzyme
in cholesterol synthesis, and was brieﬂy investigated as a potential
cholesterol lowering drug in rats [6]. This proved short-lived, becauseMechanisms of Retinal Diseases
31, Bethesda, MD 20892, USA.
ss article under the CC BY-NC-ND licthe rat liver adapted very quickly and metabolized the orally adminis-
tered 7KCh into more polar derivatives and bile acids, which were
quickly excreted [7]. 7KCh is known to activate hepatic cholesterol
7α-hydroxylase (CYP7A1) [8]. CYP7A1 is the rate-limiting enzyme in
bile acid synthesis [9], and its deﬁciency is known to cause premature
atherosclerosis in humans [10]. Other studies by a different group
have also demonstrated that dietary 7KCh is very quickly metabolized
into bile acids and excreted [8,11]. These investigators concluded that
dietary 7KCh is not the source of the 7KCh found in the atherosclerotic
plaques [11].
Another enzyme known to metabolize 7KCh is sterol 27-
hydroxylase (CYP27A1) [12]. However, Cyp27A1−/− null mice had
very little difﬁculty in metabolizing 7KCh into bile acids [13]. Thus, it
seems that CYP27A1 is unlikely to be involved in metabolizing dietary
7KCh. Another enzyme that may be involved in the hydroxylation of
7KCh is oxysterol and steroid 7-alpha-hydroxylase (CYP7B1), which is
broadly expressed in various tissues [14]. However, disruption of this
gene in mice causes no defects in bile acid synthesis [15]. This enzyme
seems to be involved in the metabolism of steroids such as androgens
and estrogens [16]. This was further conﬁrmed when the CYP7B1
knockout mouse demonstrated sexual development abnormalities
[17]. Yet another enzyme reported to be able tometabolize 7KCh is cho-
lesterol sulfotransferase (SULT2B1b) [18]. Another study demonstratedense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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formed [19]. However, SULT2B1b is expressed in very low levels in
most tissues, and its main function seems to be in regulating adrenal
androgens [20]. Thus it seems that the only enzyme that has been
clearly demonstrated to metabolize 7KCh is CYP7A1. Unfortunately,
this enzyme is only expressed in the liver [21].
In this study we examined the levels of various enzymes that have
either been previously reported and/or could potentially metabolize
7KCh in extra-hepatic tissues. We also analyzed by LCMS various
metabolites generated from7KCh in culturedARPE19 cells aswell as tis-
sues with high 7KCh content, such as the retinal pigment epithelium
and choriocapillaris [4]. Based on our results we conclude that the
main extra-hepatic metabolic pathway for 7KCh is via esteriﬁcation to
7KCh-fatty acid esters (7KFAEs), by the combined action of cytosolic
phospholipase A2 alpha (cPLA2α, to release membrane fatty acids)
and sterol O-acyltransferase (SOAT1, esteriﬁcation to fatty acids). This
is followed by efﬂux to HDL and presumably returning to the liver for
bile acid formation and excretion.
2. Materials and methods
2.1. Materials
Cholesterol (Ch) and 7-ketocholesterol (7KCh) were purchased
from Steraloids Inc. (Newport, RI). Hydroxypropyl β-cyclodextrin
(HPBCD), cholesteryl-fatty acid esters (CEs) and high density lipopro-
tein (HDL) were purchased from Sigma-Aldrich (St. Louis, MO). Fatty
acids, stearic, oleic, linoleic and linolenic were purchased from Thermo
Fisher Scientiﬁc Inc. (Waltham, MA). Acetonitrile and methanol were
purchased from Fisher Scientiﬁc (Fair Lawn, NJ). The SOAT1 selective in-
hibitor (K-604)was a kind gift fromKowa Company Ltd. (Tokyo, Japan).
The cPLA2α inhibitor (Cat# 525143) was purchased from EMD
Millipore (Billerica, MA). An afﬁnity-puriﬁed rabbit anti-SOAT1 poly-
clonal antibody was purchased from Cayman Chemicals Co. (Ann
Arbor, MI) (Cat# 100028). A polyclonal rabbit anti-GAPDH human anti-
body was purchased from Invitrogen Corp. (Carlsbad, CA). Total RNA
from adult human tissues (retina, lung, placenta, brain, liver, kidney,
heart, testis, stomach, spleen, small intestines, prostate, and skeletal
muscles) was purchased from BD Biosciences (Mountain View, CA).
RNA from human skin was purchased from BioChain (Hayward, CA).
Total cellular RNA from cultured human RPE cell lines ARPE19 and
D407 cells was isolated using TRIzol reagent (Invitrogen Corp., Carlsbad,
CA) and puriﬁed with RNeasy mini kit (Qiagen, Valencia, CA).
2.2. cDNA synthesis
Concentrations of total RNAwere determined by spectrophotometry
(Nanodrop ND-100 Spectrophotometer; Biolab, Melbourne, Vic,
Australia). Complementary DNA was synthesized from 2 μg of total
RNApreviously treatedwith DNase in a 20 μl reaction, using SuperScript
III First-strand Synthesis Systemkit (Invitrogen Corp., Carlsbad, CA). The
cDNA from each preparation was diluted 1:5, and 2 μl of each dilution
was used for real-time PCR.
2.3. Copy number determination
Expression of mRNAs from CYP7A1, CYP7B1, CYP27A1, CYP46A1,
CYP11A1, CH25H and SULT2B1b was quantiﬁed by qRT-PCR using
SYBR green in an ABI 7500 instrument (Applied Biosystems Inc., Foster
City, CA). To measure copy number, plasmid DNA was used to prepare
standards. Each gene was ampliﬁed from tissue cDNAs with full-length
ORF primers and cloned into pcDNA3.1/CT-GFP expression vector. The
DNA concentration is measured by A260 and converted to the number
of copies using the molecular weight of the DNA. Copy numbers were
determined for each test and genes assayed based upon linear regres-
sion equations from standard curve assays. Melting curve analysis wasperformed to conﬁrm production of a single product in each reaction.
PCR reactions were performed two independent times in triplicate
each time and validated by analysis of template titration and dissocia-
tion curves. Table 1 lists the primer pairs for each of the mRNAs quanti-
ﬁed in this study. The changes in gene expression were normalized to
the 18S ribosomal RNA.
2.4. Relative quantiﬁcation for qPCR
Quantitative RT-PCR was performed using Taqman ready-to-use
primer sets using an AB instrument (ABI 7500; Applied Biosystems,
Foster City, CA) according to the manufacturer's speciﬁcations.
SOAT1 (Hs00162077_m1), SOAT2 (Hs00186048_m1) and cPLA2
(Hs00233352_ml)weremeasured and normalized to the housekeeping
gene GAPD (ABI4352934E). PCR reactions were performed three inde-
pendent times in triplicate each time.
2.5. Monkey tissue collection
The monkey eyes and tissues were provided by the Pathology De-
partment of the Division of Veterinary Resources after the completion
of various NIH-wide protocols. These protocols were unrelated to this
study and the tissues were provided as a courtesy to various NIH re-
searchers. Fresh monkey eyes from 6 year old male Rhesus macaques
(Macacca mulatta) were enucleated within minutes after euthanasia
and the eyes were placed on ice.
2.6. Immunoblotting analyses
Monkey tissues and the cultured human RPE-derived cells, ARPE19
and D407, were homogenized in M-PER solution (Pierce, Rockford, IL)
containing the Complete® protease inhibitor cocktail (Roche Diagnos-
tics, Mannheim, Germany). Total protein content was determined by
the BCA method (Pierce, Rockford, IL). Protein in the cell extract was
precipitated using 10% trichloroacetic acid then collected by centrifuga-
tion at 15,000 rpm for 20 min at 4 °C. Protein samples (50 μg protein/
lane) were separated in 4–12% NuPAGE Novex Bis–Tris Gels running
in 1× NuPAGE MOPS SDS Running Buffer at room temperature for
50 min at 200 V (Invitrogen Corp., Carlsbad, CA). The proteins were
transferred using Invitrogen iBlot transfer system. Blots were blocked
in 1× TBS, pH 7.4, 5% nonfat milk, and 0.05% Tween-20, for 1 h at
room temperature and incubated with rabbit anti-SOAT1 human anti-
body at 1:1000 dilution or rabbit anti-GAPDH human antibody at
1:2000 dilution overnight at 4 °C. The blot was developed using anti-
rabbit IgG HRP conjugated secondary antibody at a dilution of
1:20,000 (KPL, Gaithersburg, MD) and imaged on X-ray ﬁlm using
SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rock-
ford, IL).
2.7. Preparation of water soluble 7KCh solution
A 10 mM stock solution was prepared by dissolving the appropriate
amount of 7KCh in 1× PBS containing 45% w/v hydroxypropyl-β-
cyclodextrin (HPBCD). Brieﬂy, an appropriate amount of 7KCh was dis-
solved in ethanol and placed in a volumetric ﬂask. The solution of 45%
HPBCD is added to 60–70% of the total volume of the ﬂask and sonicated
at 45 °C for 1 h. The remainder of the 45%HPBCD is added to the volume
of theﬂask. A 1mMworking solutionwas prepared bydiluting the stock
solution ten-fold in 1× PBS.
2.8. Cell culture
ARPE19 cells were obtained from the American Type Culture Collec-
tion (Manassas, VA) at passage 22 and grown in DMEM/F12 (1:1, by
vol., Mediatech Inc., Herndon, VA) medium containing 10% fetal bovine
serum (FBS), 2 mM glutamine, 100 IU/ml penicillin, and 100 μg/ml
Table 1
Primers for qPCR analysis.
Gene name Forward primer
5′–3′
Reverse primer
5′–3′
Size (bp) GenBank accession#
CYP7A1 AGAAGGCAAACGGGTGAACC GGGTCAATGCTTCTGTGCCC 272 NM_000780
CYP7B1 GTGCGTGACGAAATTGACCG CTCCCTTTCGCACACAGTAGTCC 220 NM_004820
CYP27A1 TCAGCATCTTCTCTGCAGACCGG TCATTAGCATCCGTGGGAACA 208 NM_005693
CYP46A1 AAGCTGGTGAGCCTGCGC CGGCAGCTTCTTGTCCTG 88 NM_007121
CYP11A1 CCCTGTTGGATGCAGTGTCT GACGCTGGTGTGGAACATCT 230 NM_000781
CH25H TCGACATGATGAACGTCACACTGCT TAAAGTGAGAGTGATGCAGGTCGTG 186 NM_003956
SULT2B1b GCTTGTGGGACACCTATGAAG ATCTCGATCATCCAGGTCGTGC 205 U92315
r18S ATGCTCTTAGCTGAGTGTCCCG ATTCCTAGCTGCGGTATCCAGG 101 NR_003286
Beta actin GATGGTGGGCATGGGTCAGAA GCTTCTCCTTAATGTCACGCAC 518 NM_001101
607J.W. Lee et al. / Biochimica et Biophysica Acta 1851 (2015) 605–619streptomycin (all from Invitrogen Corp., Carlsbad, CA). All experiments
were done within 10 passages. The D407 (human RPE) cell line was
a kind gift from Dr. Richard Hunt (Department of Pathology andFig. 1.Measurements of mRNA of several enzymes that could potentially metabolize 7KCh (CY
enzymes relative to ribosomal 18S in neural retina, lung, placenta, brain, liver and skin. Pooled
(n=1& 1), brain (n=1& 1), liver (n=3& 3) and skin (n=1& 1)was used in this study. PCR
of the various enzymes in neural retina. I. Copy number in ARPE19 cells. Data were expressed a
number is described in Materials and methods.Microbiology, University of South Carolina Medical School, Columbia,
SC) and were grown in DMEM (Mediatech, Inc, Manassas, VA) supple-
mented with 4% FBS. All cells were cultured at 37 °C with 5% CO2.P7A1, CYP7B1, CYP27A1, CYP46A1, CYP11A1, CH25H, SULT2B1b). A–G. mRNA of various
total RNA prepared from adult human retina (n = 29 & 99), lung (n = 3 & 3), placenta
reactionswere performed two independent times in triplicate each time. H. Copy number
s means ± SD from three independent experiments. The method used to determine copy
608 J.W. Lee et al. / Biochimica et Biophysica Acta 1851 (2015) 605–6192.9. 7KCh treatments
To measure Ch, 7KCh and 7KFAEs inside the cells, ARPE19 cells
were seeded in 24-well plates at a density of 150,000 cells per well, in
quadruplicate. After reaching 80% conﬂuence, themediumwas replaced
with fresh serum free medium and 7KCh–HPBCD complex (7K–HPBCD,
0–12 μM) was added directly to the wells containing the cells. This is a
critical step. Pre-diluting the 7KCh in themediawill signiﬁcantly reduce
the effective dose of 7KCh since it will adhere to the plastic walls of theFig. 2.Measurement of Ch, 7KCh, and 7KFAEs byHPLCwith ultraviolet detection (HPLC-UV). Rep
B. Extract from ARPE19 cells treated with 8 μM 7KCh for 24 h. C. Chromatograph of four 18 ca
and 400 nm.media container. The cells then were incubated at different time points.
At the indicated time, the medium was removed and the cells were
washed with PBS three times and Ch, 7KCh and 7KFAEs were extracted
using anhydrous ethanol.
2.10. Treatment of SOAT1 inhibitor and cPLA2α inhibitor
ARPE19 cells were pre-incubated with either SOAT1 selective
inhibitor (K-604) or Ca2+-dependent-cytosolic phospholipaseresentative chromatographsmonitored at 235 nm. A. Extract fromuntreated ARPE19 cells.
rbon synthetic 7KFAE standards. Insets contain the full spectra of the peaks between 200
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HPBCD treatment. After 24 h incubation, the conditioned medium was
collected, centrifuged at 1000 rpm for 5 min to remove cell debris,
then frozen and stored at−80 °C for the quantiﬁcation of secreted cyto-
kine levels. Cells were washed three times with PBS and dried at room
temperature prior to lipid extraction.2.11. siRNA knockdown of SOAT1 or cPLA2α
The siRNAs, SOAT1 (SOAT1#6, SI03246803, functionally validated
siRNA) and cPLA2α (PLA2GA4#6, SI04140402, Predesigned siRNA)
were purchased from Qiagen, Gaithersburg, MD. A nonspeciﬁc siRNA
(AllStars negative control, catalog number 1027281) was used as a neg-
ative control. The efﬁciency of the silencing was evaluated by qRT-PCR.Fig. 3.Measurements of Ch, 7KCh, 7KFAEs and CEs by LCMS. To determine the ions formed an
A. 7KCh, m/z 401 (M + H, main ion). B. Synthetic 7KFAEs, 7K18:3, 7K18:2, 7K18:1 and 7K18
Ch18:2, Ch18:1, and Ch18:0 m/z 369 (M-fatty acid, main ion). The ionization coefﬁcients for
used to quantify unidentiﬁed 7KFAEs and CEs, respectively. Insets show the MS spectra.To determinewhether downregulation of SOAT1 or cPLA2α affected
7KFAE formation and 7KCh-induced inﬂammation, ARPE19 cells were
transfected with siRNA oligos (50 nM) by electroporation using the
Nucleofector II instrument (Amaxa Biosystems, Gaithersburg, MD), ac-
cording to the manufacturer's instructions then allowed to recover for
48 h. After 24 h incubation with 8 μM 7K–HPBCD, the conditioned me-
dium was collected for cytokine assay and cells were collected to mea-
sure Ch, 7KCh and 7KFAEs.
2.12. Overexpression of SOAT1
A replication negative adenovirus that induces the overexpression of
SOAT1 in transduced cells (AdSOAT1) was purchased from SignaGen
Laboratories (Gaithersburg, MD). An adenovirus that expresses en-
hanced GFP (Vector Biolabs, Philadelphia, PA) was used as a negatived ionization coefﬁcients for the molecules of interest, 500 pmol of each standard was run.
:0. m/z 383 (M-fatty acid, main ion). C. Ch, m/z 369 (M-OH, main ion). D. CEs, Ch18:3,
the 7KFAEs and the CEs were nearly identical to each other. The average of all four was
610 J.W. Lee et al. / Biochimica et Biophysica Acta 1851 (2015) 605–619control. ARPE19 cells (50,000 cells/well) were seeded onto 24 well
plates, grown to 60% conﬂuence, and transduced with AdSOAT1 or
AdGFP in serum-free medium (MOI = 20) for 48 h. The efﬁciency of
the overexpression was evaluated by immunoblots. The transfected
cells were then treated with 8 μM 7K–HPBCD for 24 h. The conditioned
medium was collected to measure cytokine expression levels. Cells
were collected for lipid analysis. We did not detect any cell death due
to adenovirus transfection at the end of the experiment.Fig. 4. LCMS analyses of 7KCh treated and untreated ARPE19 cell extracts. The same samples fro
demonstrate the MS spectra. Bottom inset demonstrates the m/z 369 ion in the region of CEs.2.13. Cytokine assay in conditioned media
The conditioned media were centrifuged (1000 rpm × 5 min) to re-
move cell debris and stored at−80 °C until analysis. The levels of IL-1β,
IL-6, IL-8 and VEGF proteinweremeasured using the Luminexmagnetic
bead immunoassay technology following the manufacturer's protocol.
Brieﬂy, 25 μl of conditioned medium was added to the pre-wet plate
containing 25 μl of assay buffer. To eachwell, 25 μl of multiple premixedm Fig. 2 were analyzed by LCMS. A. Untreated cells. B. Cells treatedwith 8 μM7KCh. Insets
Amounts (pmols) are listed for each component.
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incubated with agitation on a plate shaker for 18 h at 4 °C. The wells
were washed twice with 200 μl Milliplex wash buffer. The beads were
shakenwith 25 μl of the detection antibodymix for 2 h at room temper-
ature; each antibody is speciﬁc to a single cytokine/chemokine. The
beads were shaken with 25 μl of the streptavidin–phycoerythrin solu-
tion for 30 min at room temperature and washed twice again. The
beads were suspended in each well with 150 μl of the Milliplex dry
ﬂuid in a shaker for 5 min. The plate was read on MAGPIX Luminex
xMAP instrument (Luminex Corp., Austin, TX) and analyzed with
Milliplex Analysis software version 3 (EMD Millipore Corporation, Bil-
lerica, MA). The concentration of each cytokine was determined using
the array reader. A parallel standard curve was constructed for each cy-
tokine. The cytokine levels were normalized toml of conditionedmedia
volume.
2.14. Cell viability assays
ARPE19 cells were treatedwith 2–15 μM7K–HPBCDwith orwithout
other compounds for 24 h. Cell viability wasmeasured by cellular dehy-
drogenase activity using a cell counting kit (Cell CountingKit-8; Dojindo
Molecular Technologies, Gaithersburg, MD). Each measurement was
performed in quadruplicate except where noted.
2.15. Synthesis of 7KFAEs
The synthesis of 7KFAEs was reported by Brown et al. [3] and
Freeman et al. [22]. However, in this study we synthesized 7KFAEs by
the modiﬁcation of a previous protocol for the synthesis of labeled tri-
glycerides [23]. We have found that this method provides a higher
yield and fewer side products. In brief, 0.1 mmol of fatty acid (stearic,
28.4 mg), 0.26 mmol 7KCh (104.1 mg) and 0.12 mmol 4-dimethyl-
aminopyridine (14.6 mg) were weighed. These materials were mixed
and dissolved in 0.5ml ofmethylene chloride (MeCl) in an ampule. Sep-
arately 0.16 mmol N,N-dicyclohexyl carbodiimide (33.0 mg) wasFig. 5. Kinetics of 7KFAE formation. ARPE19 cells were grown and treated as described above. A
tions. B. 7KCh accumulation and 7KFAE formation over time (8 μM7KCh treatment). C. Percenta
age of 7KCh converted to 7KFAEs over time (8 μM 7KCh treatment). The 7KFAEs were prese
Data were expressed as means ± SD from three independent experiments.weighed and dissolved in 0.5 ml MeCl. Both solutions were mixed in
the ampule, ﬂushed with argon gas and then the ampule was sealed.
The reaction was allowed to run at room temperature overnight.
These proportions were used to synthesize other 7KFAEs. In total four
7KFAEs were synthesized, 7K-18:3 (linolenic), 7K-18:2 (linoleic),
7K18:1 (oleic) and 7K18:0 (stearic). 7KFAEs synthesized from arachi-
donic (20:4) and decosahexaenoic acids proved to be too unstable in
DMSO and ethanol solutions and were not used in this study. The
7KFAEswere puriﬁed by preparativeHPLCusing a tertiary gradient sim-
ilar to the one used for the analytical quantiﬁcations.
2.16. Analyses of Ch, 7KCh, 7KFAEs and CEs
The lipids were extracted by adding 250 μl of dried-ethanol to each
well. The ethanol soluble fraction was collected from 4 wells from
each sample and evaporated, dissolved in N,N-dimethylformamide
(DMF) and injected directly into the LC. Most of the identiﬁcation and
quantiﬁcation of Ch, 7KCh and 7KFAEs was performed by HPLC-UV.
This method is quicker and simpler than by LCMS. In the cases where
we also wanted to measure the CE content, LCMS was used since the
stronger solvent needed to elute them from the column interfered
with their quantiﬁcation by UV since their UV absorption maxima is
around 200 nm.
2.17. HPLC-UV
TheHPLC-UV analyseswere performed using aWaters 2695 appara-
tus running Empower 2 software and a 2996 photodiode array detector.
The column used was Phenomenex Luna C-8 (3 μm) 2.0 × 250 mm
(Torrance, CA) running at 0.25 ml/min. The 7KCh, Ch and 7KFAEs
were eluted in a tri-phasic gradient with initial conditions of 25%
water and 75% acetonitrile (AcN). The ﬁrst gradient raised the AcN con-
centration to 100% in 5 min. This was followed by a second gradient
from 100% AcN to 50% AcN, 50% methanol (MeOH) over 15 min. The
AcN–MeOH mixture was maintained for another 15 min to elute all of. Accumulation of 7KCh and 7KFAEs during 24 h of incubation in various 7KCh concentra-
ge of 7KCh converted to 7KFAEs in response to increasing 7KCh concentration. D. Percent-
nted as % of 7KFAEs levels in the cells versus total 7KCh levels (free 7KCh plus 7KFAEs).
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conditions for a total of 40 min per run. 7KCh was quantiﬁed at
238 nm and Ch at 200 nm using standard curves for each. The 7KFAEs
were quantiﬁed at 234 nm. The extinction coefﬁcients of the synthetic
7KFAEs were nearly identical, thus the average of the four was used to
quantify all 7KFAEs.2.18. HPLC-mass spectroscopy (LCMS)
Identiﬁcation and quantiﬁcation of 7KCh, Ch and the 7KFAEs was
also performed by LCMS. The separation was performed using an
Agilent 1200 Series HPLC (Santa Clara, CA) equipped with an auto-
sampler and a 1260 Quad pump. The column used was a Varian XRs
ultra 2.8 μm, 2 × 100 mm running at 0.15 ml/min. A tri-phasic gradient
was used starting with 30% water, 70% AcN to 100% AcN in 15 min. A
second gradient was then started from 100% AcN to 100% MeOH to
30 min. A third gradient went from 100% MeOH to 100% MeOH–meth-
ylene chloride (50:50 mix) to 40 min. This 3rd gradient is needed to
elute the 7KFAEs and the CEs. The re-equilibration takes anotherFig. 6. Expression of SOAT1 and 2 in human tissues. A. Expression of SOAT1mRNA in human ne
the same tissues. C. Expression of SOAT1mRNA inmultiple human tissues. D. Expression of SOA
experiments. E. Immunoblot showing the expression of SOAT1 protein in monkey liver, monke20 min. In the ﬁrst 5 min the column is ﬂushed with 100% AcN then
switched to the starting solvent, 30% water 70% AcN for an additional
15 min. Thus each injection runs for 1 h. The MS used was a Water/
Micromass Q-TOF micro using atmospheric pressure ionization in posi-
tive mode (APCi+). Masslynx software version 4.1 (Waters, Milford,
MA) was used to analyze the data. 7KCh was quantiﬁed using the
M + H m/z 401 ion and Ch using the M-OH m/z 369 ion as previously
described [4]. The 7KFAEs were quantiﬁed using the M-fatty acid m/z
383 ion. This is the M-OH 7KCh ion which is also formed in small
amounts by 7KCh. The ionization coefﬁcients for the synthetic 7KFAEs
were nearly identical. An average of the four was used to quantify all
7KFAEs.2.19. Statistical analysis
Statistical comparisons between groups were performed using two-
tailed Student's t-test. We consider the result as signiﬁcant when
p b 0.05. Data are shown as means ± SD. All calculations were done
using Prism software (GraphPad, San Diego, CA).ural retina, liver and the RPE derived cell lines ARPE19 and D407. B. Expression of SOAT2 in
T2 inmultiple human tissues. Datawere expressed asmeans± SD from three independent
y neural retina, monkey RPE/choroid and the RPE derived cell lines ARPE19 and D407.
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3.1. Expression levels of various enzymes that could potentially metabolize
7KCh in various human tissues and cultured ARPE19 cells
In order to determine if 7KCh could bemetabolized by extra-hepatic
tissue we measured the expression (by qRT-PCR) of seven enzymes
CYP7A1, CYP7B1, CYP27A1, cholesterol 24-hydroxylase (CYP46A1),
cholesterol monooxygenase (side-chain-cleaving) (CYP11A1), 25-
cholesterol hydroxylase (CH25H), and SULT2B1b in six human tissues
(Fig. 1). As mentioned above, previous studies have shown that
CYP7A1 [8,21], CYP27A1 (11), and SULT2B1b [18,19] are capable of me-
tabolizing 7KCh. As previously reported [21] CYP7A1 is liver speciﬁc
(Fig. 1A). CYP7B1 is broadly expressed [14] but at relatively low levels
in all of the tissues tested (Fig. 1B). CYP27A1 is also broadly expressed
at low levels with the exception of the liver (Fig. 1C). CYP46A1 is
expressed almost exclusively in thebrainwith about one-tenth (relative
to brain) expression in retina (Fig. 1D). CYP11A1 is almost exclusively
expressed in placenta (Fig. 1E). CH25H is broadly expressed especially
in the lung (Fig. 1F). SULT2B1b is almost exclusively expressed in the
skin with much smaller levels in lung and placenta (Fig. 1G) with noFig. 7. Effects of SOAT1 and cPLA2α inhibition on 7KCh-induced inﬂammation and cell death. A
K-604 on 7KFAE formation. B. Effect of cPLA2α inhibitionwith cPLA2α inhibitor on 7KFAE forma
IL-6, IL-8 and VEGF were measured as described above. D. Effect of cPLA2α inhibition on 7KCh
7KCh-induced cell death. Datawere expressed asmeans± SD from six independent experimen
to 7KCh treated of each group.detectable expression in the retina. We also measured the mRNA copy
number of these enzymes in human neural retina (Fig. 1H) and
ARPE19 cells (Fig. 1I). The copy number for all of the enzymes is low
as compared to β-actin. CYP27A1 has the highest in both, but SULT2B1b
levels are essentially nil.
The low level or complete lack of expression of some of these
enzymes (CYP7A1, CYP11A1, and SULT2B1b) suggests that they are un-
likely to participate in the metabolism of 7KCh in the retina. However,
the moderate level of expression of some of the other enzymes
(CYP7B1, CYP27A1, CYP46A1 and CH25H) indicates that they could
potentially be involved in the extra-hepatic metabolism of 7KCh in the
retina.
3.2. Search for 7KCh metabolites in 7KCh-treated ARPE19 cells
The search for 7KCh metabolites was initially performed by HPLC-
UV using lipid extracts from ARPE19 cells that were treated with 7K-
Ch. The main differences observed between the untreated (Fig. 2A)
and treated cells (Fig. 2B) were the formation of various hydrophobic
components with λmax at 235 nm. The identity of these components
was immediately known but we suspected, by the signiﬁcant increaseRPE19 cells were grown and treated as described above. A. Effect of SOAT1 inhibition with
tion. C. Effect of K-604 treatment on 7KCh-induced cytokine release in conditionedmedia.
-induced cytokine release in conditioned media. E. Effect of K-604 or cPLA2α inhibitor on
ts. *p b 0.05 compared to untreated control sample of each group or inhibitor treated group
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not available commercially, therefore we synthesized four potential es-
ters, 7K18:0 (stearic), 7K18:1 (oleic), 7K18:2 (linoleic) and 7K18:3
(linolenic) as described above. The retention times of the synthetic
7KFAEs were similar to those found in the 7KCh-treated cells and their
UV spectra were nearly identical (Fig. 2C).
To further conﬁrm the identity of the 7KFAEs, authentic standards
were analyzed by LCMS as described above. 7-KCh generates a main
M + H+ ion with m/z of 401. It also forms a minor M-OH+ ion with
an m/z of 383 (Fig. 3A). 7KFAEs also generated an m/z of 383 since theFig. 8. Effects of siRNA knockdown of SOAT1 or cPLA2α on 7KCh-induced inﬂammation and cel
cPLA2α-speciﬁc siRNA (sicPLA2α) (B, D, F, G) as described above. A. Knockdown of SOAT1 mR
B. Knockdown of cPLA2αmRNA expression using sicPLA2α versus negative control with and w
in triplicate each time. C. Effect of siSOAT1 on the formation of 7KFAEs. D. Effect of sicPLA2α on th
mediawith andwithout 7KCh treatment. F. Effect of sicPLA2α on cytokine levels released into th
on 7KCh-induced cell death. Data were expressed as means ± SD from three independent expAPCi probe fragments the parent molecule and creates an M-fatty acid
positive ion (Fig. 3B). Cholesterol (Ch) generates an M-OH+ ion of m/z
369 (Fig. 3C) with small amounts of M-H+ (m/z 385). Cholesteryl
fatty acid esters (CEs) also generate M-fatty acid ions of m/z 369
(Fig. 3D). The extinction and ionization coefﬁcients of all of the synthe-
sized 7KFAEs and CEs were nearly identical to each other. Hence, we
used the average of all four coefﬁcients for quantiﬁcation of unknown
esters.
Analyses of the same samples from Fig. 2 by LCMS revealed similar
but more detailed information (Fig. 4). The untreated cell extractsl death. ARPE19 cells were treatedwith an SOAT1-speciﬁc siRNA (siSOAT1) (A, C, E, G) or a
NA expression using siSOAT1 versus negative control with and without 7KCh treatment.
ithout 7KCh treatment. Data were expressed as mean from two independent experiments
e formation of 7KFAEs. E. Effect of siSOAT1 on cytokine levels released into the conditioned
e conditionedmediawith andwithout 7KCh treatment. G. Effect of siSOAT1 and sicPLA2α
eriments. *p b 0.05 compared to negative siRNA (siNegative) treated group.
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detectable levels of 7KFAEs or CEs (Fig. 4A). The 7KCh-treated sample
obviously had a lot more intracellular 7KCh (650 pmol 7KCh/nmol Ch)
but also showedm/z 383 peaks consistent with 7KFAEs (Fig. 4B). In ad-
dition to the 3 main peaks detected by UV (Fig. 2) the MS detected 4–5
other smaller peaks (Fig. 4B). The combination of the 7KFAEs isFig. 9. Effects of SOAT1 overexpression on intracellular 7KCh levels, 7KFAEs synthesis, 7KCh-ind
ative adenovirus containing SOAT1 (AdSOAT1) as described above. A. Immunoblot developed
extracts. B. Effect of AdSOAT1 transduction on intracellular 7KCh levels (mean ± S.D., n= 4).
C. Effect of AdSOAT1 transduction on 7KFAE synthesis. D. Effect of AdSOAT1 transduction on th
experiments. The levels of IL-6, IL-8 and VEGF were measured in the conditioned media from A
duction. Experimental details are described above. E. Effect of AdSOAT1 on IL-6. F. Effects of Ad
death. Data were expressed as means ± SD from three independent experiments. Each measuapproximately 219 pmol (Fig. 4B). More interestingly it also detected
a small amount of m/z 369 peaks consistent with CEs. Although these
peaks seem insigniﬁcant next to Ch (440 pmol), the three main peaks
account for 35 pmol (7.4% of total Ch). APCi+ ionization is not ideal
for CE detection and the ionization coefﬁcient for CEs is approximately
1/3 that of Ch. However, the CEs are unequivocally detected and notuced cytokine release and cell death. ARPE19 cells were transducedwith a replication neg-
with anti-SOAT1 antibodies demonstrating SOAT1 overexpression in ARPE19 cell protein
The levels were normalized to proteins. *p b 0.05 compared to AdGFP transduced group.
e rate of 7KFAEs synthesis. Data were expressed as means ± SD from three independent
RPE19 cells treated with HPBCD (carrier), Ch and 7KChwith and without AdSOAT1 trans-
SOAT1 on IL-8. G. Effect of AdSOAT1 on VEGF. H. Effect of AdSOAT1 on 7KCh-induced cell
rement was performed in duplicate.
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an enzyme that also generates CEs. Thismay also be the reason Ch levels
drop in response to 7KCh treatment.
We have also searched for hydroxylated and sulfated forms of
7KCh in 7KCh-treated ARPE19 cells as well as in monkey and human
RPE/choroid tissue which have signiﬁcant levels of 7KCh [4,5].
We have not found any detectable levels of hydroxylated or sulfated
forms of 7KCh (data not shown). There were detectable levels of 7-
hydroxycholesterol (7HCh). This oxysterol is formed by the samemech-
anism as 7KCh and will further oxidize to 7KCh. In the human and
monkey RPE/choroid tissue, aside from signiﬁcant amounts of 7KCh,
7HCh and CEs, we also detected very small amounts of 24- and 27-
hydroxycholesterol (data not shown). However, these two oxysterolsFig. 10. Effect of HDL on 7KFAE efﬂux. ARPE19 cellswere treatedwith the increasing amounts of
commercially available HDL. B. Effect of increasing amounts of HDL on 7KCh-induced cell death
independent experiments. Each measurement was performed in duplicate. *p b 0.05 compared
HDL treatment. C. Effect of HDL on the efﬂux of 7KFAEs into the conditioned media with and w
without AdSOAT1 transduction. E. Effect of HDL on the efﬂux of 7KCh into the conditioned m
7KCh with and without AdSOAT1 transduction.are present in blood and may be the reason they were found in the
RPE/choroid tissue. The choriocapillaris is impossible to dissect free of
blood without perfusion prior to euthanasia and dissection.
The formation of 7KFAEs and the small but detectable increase in CEs
led us to suspect the involvement of SOATs since these enzymes are
known to synthesize CEs [24].
3.3. Kinetics of 7KFAE formation
In order to better understand how 7KCh interacted with the ARPE19
cells and the process of 7KFAE formation, several experiments were
performed to determine the concentration range and time needed for
synthesis.HDL (1–10 μg) in the presence of 7KCh (12 μM) as described above. A. HPLC-UV analysis of
with and without AdSOAT1 transduction. Data were expressed asmeans± SD from three
to AdGFP transduced group. **p b 0.05 compared to AdSOAT1 transduced group without
ithout AdSOAT1 transduction. D. Effect of HDL on intracellular levels of 7KFAEs with and
edia with and without AdSOAT1 transduction. F. Effect of HDL on intracellular levels of
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0–8 μM. Doses above 8 μM are lethal within 24 h and 4 μM is needed to
initiate an inﬂammatory response [25]. The 7KFAEs were quantiﬁed
by LC-UV as described above. Values are normalized to cholesterol
(Ch). The results indicate that 7KFAEs are not synthesized until
7KCh levels are at 2 μM or above (Fig. 5A). At 8 μM 7KCh reaches a
1:1 ratio with cholesterol (Fig. 5A) and this takes approximately
3 h (Fig. 5B). Approximately 25–30% of the internalized 7KCh is
converted to ester if 7KCh is given in doses above 6 μM (Fig. 5C).
The 7KFAE synthesis continues steadily for 24 h but changes little be-
tween 24 and 48 h (Fig. 5D).
Thus, to reach the maximum level of 7KFAE formation it requires
6–8 μM 7KCh and about 24 h. The capacity to store the 7KFAEs seems
to saturate after 24 h of 7KCh exposure.3.4. Expression of SOAT1 and 2 in cultured cells and human tissues
As mentioned above, the enzymes most likely to be involved in the
synthesis of 7KFAEs would be the SOATs [26]. SOATs are known to syn-
thesize cholesterol fatty acid esters using fatty acids released from
membrane phospholipids [24]. There are two known SOATs, SOAT1
and SOAT2. To determine the involvement of the SOATs in the synthesis
of 7KFAEs, their mRNA expression was measured (by qRT-PCR) in
human retina, liver and in two RPE-derived cultured cells, ARPE19 and
D407 (Fig. 6A, B). SOAT1 was expressed in roughly equal levels in the
four tissues tested (Fig. 6A). SOAT2 was highly expressed in human
liver, but there was little expression in human retina and it was barely
detectable in the cultured cells (Fig. 6B). We then examined their ex-
pression in a variety of human tissues (Fig. 6C, D). SOAT1 is expressed
in most tissues (Fig. 6C), while SOAT2 seems to be more selective
(Fig. 6D) as previously reported [27]. SOAT2 is almost exclusively
expressed in the small intestines and liver. Since there is little expres-
sion of SOAT2 in retina and in the RPE-derived cell lines, all of the sub-
sequent work was focused on SOAT1.
At the protein level immunoblots show that SOAT1 is expressed in
monkey liver. The two RPE-derived cell lines express the full size pro-
tein (MW: 65 kDa) and possibly a dimer (Fig. 6E) [28]. Human retinal
tissue is difﬁcult to obtain without considerable postmortem time,
therefore monkey retina was used. Themonkey retina and RPE/choroid
tissues express a smaller fragment which may be due to proteolysis in
the sample (Fig. 6E).3.5. Inhibition of SOAT1 and its partner cytosolic phospholipase 2A
(cPLA2α)
Initially we investigated cPLA2α because of its connection to inﬂam-
mation. This enzyme is known to release arachidonic acid, which is the
precursor for prostaglandins and leukotrienes [29]. However, it soon be-
came evident that cPLA2αwasworkingwith SOAT1 to form the 7KFAEs
[22].
To determine if these two enzymes were indeed responsible for the
formation of the 7KFAEs and potentially mediate the 7KCh-induced
inﬂammation, we inhibited their function using K-604 (SOAT1) and
cPLA2α inhibitor (cPLA2α) in 7KCh treated ARPE19 cells (Fig. 7). Inhibi-
tion of SOAT1 (Fig. 7A) and cPLA2α (Fig. 7B) ablated the 7KFAE forma-
tion. This inhibition had no signiﬁcant effect on the 7KCh-induced
cytokine release (Fig. 7C, D) or on protecting the cells from 7KCh-
induced cell death (Fig. 7E). Both inhibitors demonstrated a statistically
signiﬁcant drop in IL-8. However, we have no other evidence to suggest
that the cPLA2α and SOAT1 are involved in mediating any of the 7KCh-
induced inﬂammatory responses. Other work from our group has
shown that most of the 7KCh-induced inﬂammatory and cell death
responses are mediated by the activation of the Toll-like receptor 4
(TLR4) [30].3.6. Knockdown of SOAT1 and cPLA2α using siRNAs
Since inhibitors may at times have other non-speciﬁc properties, we
wanted to further demonstrate the involvement of SOAT1 and cPLA2α
on the synthesis of 7KFAEs by a different method. We used siRNAs to
knock down themRNA expression of SOAT1 and cPLA2α andmeasured
the effect on the 7KFAE synthesis, cytokine production and cell viability
(Fig. 8).
ARPE19 cells were transfectedwith an SOAT1 and a negative control
siRNA as described above. The siRNA knockdown of SOAT1 was very
effective and was not affected by 7KCh treatment which causes a slight
induction of SOAT1mRNA (Fig. 8A). The knockdown of SOAT1 did have
a signiﬁcant effect on the reduction of 7KFAE synthesis (Fig. 8C). How-
ever, as with the inhibitors it had little effect on the cytokine inductions
(Fig. 8E). The SOAT1 knockdown also failed to protect the cells from
7KCh-induced cell death (Fig. 8G).
An identical series of experiments using a cPLA2α siRNA yielded
very similar results (Fig. 8B, D, F, G). The siRNA was very effective at re-
ducing the cPLA2αmRNA levels even though 7KCh does cause a signif-
icant induction (Fig. 8B). The cPLA2α siRNA caused only a moderate
reduction in 7KFAE synthesis (Fig. 8D). It had little or no effect on the
7KCh-induced cytokine production (Fig. 8F) and also failed to protect
cells from 7KCh-induced cell death (Fig. 8G).
The siRNAs were not as effective as the inhibitors at reducing SOAT1
and cPLA2α activities (Fig. 7). This is likely due to the existing levels of
these enzymes present in the cells and their relatively slow turnover.
However, the effects were consistent with those caused by the inhibi-
tors (Fig. 7).
3.7. Overexpression of SOAT1
The inhibition or knockdown of SOAT1/cPLA2α had no signiﬁcant
biological effect on 7KCh-induced inﬂammation and cell death. To fur-
ther investigate this effect overexpression of SOAT1 was performed by
transducingARPE19 cellswith a commercially available replication neg-
ative adenovirus (AdSOAT1) as described above. A similar adenovirus
overexpressingGFPwas used as a negative control (AdGFP). The immu-
noblot indicates that there is a signiﬁcant level of overexpression in the
AdSOAT1 transduced cells butmost of the immunoreactive protein is an
amorphous aggregate of various molecular weights (Fig. 9A) as previ-
ously reported [31]. After transduction the cells were treated with
8 μM 7KCh and the levels of 7KCh, Ch and 7KFAEs were quantiﬁed by
LCMS. The overexpression caused a signiﬁcant drop in intracellular
7KCh (Fig. 9B) and a signiﬁcant increase in intracellular 7KFAEs
(Fig. 9C). It also altered the kinetics of 7KFAE formation by signiﬁcantly
increasing the rate of synthesis (Fig. 9D). More importantly, SOAT1
overexpression signiﬁcantly reduced the 7KCh-induced expression of
IL-6 (Fig. 9E) and IL-8 (Fig. 9F) but had no effect on VEGF (Fig. 9G).
Interestingly, it provided a moderate but statistically signiﬁcant level
of protection from 7KCh-induced cell death (Fig. 9H).
This positive effect caused by the SOAT1 overexpression is likely
due to the signiﬁcant reduction of intracellular 7KCh levels below the
threshold that induces inﬂammation and cytotoxicity.
3.8. HDL increases 7KFAE efﬂux and protects cells from 7KCh-induced cell
death
While performing HPLC analyses on commercially purchased HDL
and LDL samples, we observed that HDL contained (aside from Ch and
CEs) a small amount of 7KCh and other components that we recognized
as 7KFAEs (Fig. 10A). LDL by contrast containsmuch higher levels of CEs
(approximately 60% of total Ch) but no 7KFAEs (data not shown).
This suggested that the missing element in the extra-hepatic 7KCh
metabolism may be HDL.
The ARPE19 cells were treated with a lethal dose of 7KCh (12 μM) in
combination with different amounts of HDL in the media with and
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SOAT1 overexpression protects the cells but this protection is enhanced
by the presence of HDL at 5 μg/ml and higher (Fig. 10B).
To determine if this protection is occurring due to 7KCh and 7KFAE
efﬂux to HDL, lipid extracts from the samples in Fig. 10A were analyzed
by LCMS. The presence of HDL in the conditioned media (CM) signiﬁ-
cantly increased the levels of 7KFAEs in the CM (Fig. 10C) but no signif-
icant change in 7KCh levels was observed (Fig. 10D, E).
Interestingly, the intracellular levels of 7KFAEs also increased in the
presence of HDL (Fig. 10D) suggesting HDL may be further stimulating
their synthesis. This suggests that HDL preferentially efﬂuxes 7KFAEs.
The intracellular levels of 7KCh were decreased in a dose-dependent
manner in both cells with andwithout SOAT1 overexpression (Fig. 10F).
This data suggests that HDL can function not only in returning excess
CEs to the liver but it can also aid in removing 7KCh in the form of
7KFAEs from extra-hepatic tissues.4. Discussion
7-KCh accumulates in signiﬁcant levels in the back of the retina [4,5].
It is associated with lipoprotein deposits and other lipid debris that ac-
cumulates in Bruch's membrane and the choriocapillaris as a conse-
quence of aging [4,5,32]. This 7KCh accumulation is suspected of
causing a chronic inﬂammatory response that in some individuals
could initiate the pathogenesis of age-related macular degeneration
[1]. In human and drusen samples from elderly donors the accumula-
tion can reach mM levels [5], which leads us to suspect that most of
the 7KCh is sequestered in lipoprotein deposits and not readily available
to the surrounding tissues. However, it is likely that any tissue in the
vicinity of those 7KCh-laden deposits will likely be in a chronic stage
of inﬂammation and at risk of receiving a lethal dose.
In this study we investigated various potential pathways for
extra-hepatic 7KCh metabolism. Our data suggests that hydroxylation
and/or sulfation are not likely to be involved in any signiﬁcant way
(Figs. 1–4). The rationale for this is two-fold; 1) we cannot ﬁnd any of
the hydroxylated or sulfatedmetabolites, 2) the enzymes that could po-
tentially perform these reactions are either completely absent (CYP7A1,
CYP11A1, SULT2B1b) or expressed at relatively low levels (CYP7B1,
27A1, 46A1) in the retina and/or in most extra-hepatic tissues. The
two best candidates CYP27A1 and CYP46A1 could form 27-hydroxy-
7KCh and 24-hydroxy-7KCh. However, we failed to detect these two
compounds in cultured cells treated with 7KCh as well as in monkey
and human samples of RPE/choroid tissues which contained very high
levels of 7KCh [4,5]. The only 7KCh derivatives that we have detected
are the 7KFAEs (Figs. 2–4). These are readily detected in lipid extract
from 7KCh treated cells and commercially available HDL. In the RPE/
choroid of monkey and human samples we readily detect 7KCh, 7HCh
(which is epimeric), Ch and CEs but generally no 7KFAEs [4,5].
We hypothesize that there are two main reasons that explain the
lack of 7KFAEs in biological samples (exceptHDL). First, the 7KFAEs can-
not form fromCE-rich deposits.Most CEs in lipoprotein deposits contain
polyunsaturated fatty acids which will oxidize simultaneously with Ch
during autooxidation (Fenton reaction). This will generate a complex
mixture of molecules that will break apart the ester bond leaving the
oxidized cholesteryl moiety further oxidizing mostly to 7KCh and the
oxidized fatty acids. The second reason, as we have observed during
the synthesis and manipulation of 7KFAEs, is that they are unstable.
The higher the degree of unsaturation, the more unstable the 7KFAE.
Therefore, the fate of the oxidized CEs in lipoprotein deposits is the for-
mation of mostly 7KCh (from the cholesteryl moiety) and oxidized fatty
acids. The oxidized fatty acids are signiﬁcantly more soluble than 7KCh
andwill likely leech out into circulation over time and be cleared by the
kidneys. In monkeys and especially humans this is a process that can
takemany decades and is unique (in terms of time and degree of oxida-
tion) to each individual. Therefore, the 7KFAEs observed in HDL withunoxidized fatty acids moieties are likely those synthesized by the
cPLA2α/SOAT1 using unoxidized membrane fatty acids.
Our data suggests that HDL can selectively remove 7KFAEs from
cells. Low doses of HDL (5–10 μg/ml) can signiﬁcantly protect cells
from 7KCh-induced cell death, especially when 7KFAE formation is en-
hanced by the overexpression of SOAT1 (Fig. 10). The presence of signif-
icant levels of 7KFAEs in commercially available HDL suggests that this
may be the pathway for returning 7KCh to the liver, which seems to
be the only tissue that can properly detoxify 7KCh. To our knowledge
this is a novel function for HDL.
The beneﬁts of high HDL levels and its role in the “reverse cholester-
ol” pathways have been well documented [33]. HDL is known as the
“good” cholesterol while LDL, which is a much larger particle highly
enriched in CEs, is considered the “bad” cholesterol [33]. HDL in combi-
nation with the cholesterol ester transfer protein (CETP) moves CEs to
and from LDL. The HDL containing CEs returns to the liver where Ch is
converted into bile acids and excreted. Our data suggests that HDL
may also help cells that are in contact with oxidized LDL deposits with
high levels of 7KCh, to efﬂux the 7KFAEs synthesized via the cPLA2α/
SOAT1 (Fig. 10). As we have shown in our in vitro model, this reduces
the inﬂammatory response, and helps preserve cellular function and
viability.
In summary, there is no “real” extra-hepaticmetabolismof 7KCh. The
formation of 7KFAEs is not themain function of cPLA2, SOAT1 and HDL.
Accumulation of lipoprotein deposits and subsequent oxidation occurs
late in life and this pathway has not beneﬁted from natural selection.
Thus, in its present form this is an inefﬁcient and insufﬁcient pathway
to clear 7KCh from lipoprotein deposits. This is an example of cells
using available resources to deal with a problem (7KCh accumulation)
they are not evolutionarily equipped to handle. However, this study
does provide additional insight into how extra-hepatic tissues are
handling 7KCh accumulation and how HDL may be aiding in 7KCh
elimination.
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